News

An international research team has succeeded in characterising different immune responses of tuberculosis patients and identifying groups of patients who either showed a very low or a very strong

Viruses and bacteria do not stop at national borders. International collaboration is the only way to meet the global challenges in infection research. Since its foundation, the German Center for

We are deeply saddened to learn of the untimely death of our long-time friend, colleague and companion, Prof. Reinhold E. Schmidt.

Reinhold Schmidt has been involved in the DZIF from the very

Hepatitis E virus (HEV) can cause serious liver inflammation and is the most common cause of acute virus-mediated hepatitis worldwide. Infection can be prevented through appropriate hygiene measures

Infection with SARS-CoV-2 leaves some people almost unaffected, while others develop life-threatening COVID-19 symptoms. So far, we do not understand exactly why symptoms and disease severity

Bloodstream infections (BSI) are serious bacterial infections associated with high mortality. A research team developed the clinical BLOOMY* scores in order to identify risk factors and thus be able

A new study from Munich shows that the immune system develops a high-quality antibody response after a total of three encounters with the viral spike protein of SARS-CoV-2. These antibodies can also

With INCATE (INCubator for Antibacterial Therapies in Europe), the German Center for Infection Research (DZIF) has participated in the foundation of a European initiative to take up the fight against

Despite improved methods of treatment, an infection with the hepatitis C virus still leads to approximately 400,000 deaths worldwide each year. The development of a vaccine is urgently required, but

The Epstein-Barr virus (EBV) has been known for some time to play a part in a range of diseases. A current US study has now shown a close link between EBV and multiple sclerosis. DZIF scientists at